/ /

  • linkedin
  • Increase Font
  • Sharebar

    What physicians need to know about bacterial resistance

    La Jolla, CA—In vitro antibiotic resistance—defined as the ability for bacteria to exist and multiply despite a normally achievable serum level of drug that had been previously determined to successfully treat a clinical infection—is an increasing problem worldwide.

    Resistance is determined based on serum standards, however. Taking into account the high concentrations of antibiotic achievable in ocular tissues, antibiotic resistance does not necessarily correspond with poor clinical efficacy when treating infections in ophthalmology, said Francis S. Mah, MD.

    Related: Photoactivation holds promise for keratitis treatment

    Regional data on antibiotic minimum inhibitory concentration (MIC) and resistance rates are factors ophthalmologists should consider when choosing antibiotics for prophylaxis and as empiric treatment, said Dr. Mah, director, cornea and external diseases and co-director, refractive surgery, Scripps Clinic Torrey Pines, La Jolla, CA.

     

     

    New Call-to-action

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results